Start Searching Today!

Type a URL to search registration information about any website

2-sight Sign Up Information

Last Updated:
Site Encrypted:
Site Category:
Email Verified:
Data Held

Email Address


Your Address

 Home Address, City, State, Zipcode

Post-Registration Data

We are still gathering data about this website


This site did not show evidence of storing passwords in plaintext.

This site does allow secured connections (https)

This site did show a clear way to unsubscribe from their emails

This site does verify your email address.

Membership Emails

Below is a sample of the emails you can expect to receive when signed up to 2-sight.

Hi Jon,


Thank you kindly for reaching out to us. Unfortunately, Second Sight recently announced we have suspended the production of Argus® II Retinal Prosthesis System (RP Retinal Prosthesis Implantable device) surgeries in order to accelerate the development of the Orion® Cortical Prosthesis System. 


While, the Argus II is intended to only treat people with profound Retinitis Pigmentosa, the Orion Cortical Prosthesis System is intended to treat nearly all forms of blindness, including Retinitis Pigmentosa. We are truly excited for this clinical next-generation device and the potential to provide functional vision to more people than ever before.


I would be more than happy to assist you with more information on the Orion Cortical Prosthesis System.


The Orion is an implanted cortical stimulation device with potential to provide a form of useful vision to individuals who are blind due to a wide range of causes including glaucoma, diabetic retinopathy, optic nerve injury or disease, or forms of cancer and trauma.


The Orion System converts images captured by a miniature video camera mounted on glasses into a series of small electrical pulses. The device bypasses diseased or injured eye anatomy and transmits these electrical pulses wirelessly to an array of electrodes implanted on the surface of the brain’s visual cortex, to provide the perception of patterns of light.


The device is not available commercially. A six-patient, feasibility study of the Orion I is currently underway in the U.S. at the Ronald Reagan UCLA Medical Center and Baylor College of Medicine in Houston.


Below is the link to our government webpage with information regarding the ongoing 5 year Orion Early Feasibility Study including the inclusion and exclusion criteria. Please review for more information about the general requirements that were in place during our last enrollment.


Additionally, I have provided a few additional links that I hope you find to be informative.

Baylor College of Medicine Article & Video:

CNET segment:

CBS News:


Please call back if you have any additional questions, we would be happy to further assist you.


Kind Regards,




Alma Abarca-Meraz

Sr. Customer Service Representative

12744 San Fernando Road. Suite 400

Sylmar, CA 91342 USA

Direct Desk: 1(818) 833-4159











From: @ [mailto:@]
Sent: Wednesday, November 13, 2019 5:22 AM
Subject: Second Sight Contact Form


Name: Jon
Practice: Jon
Phone: Jon
Email: @

Address1: 183 Langham Road
Address2: 142 Langham Road
City: London
Zip: 90275

Brochures: Jon

Approx # of Retinitis Pigmentosa patients seen annually?

Interested in being invited to SSMP sponsored events at major shows? Yes,No

Physician Name:
Home address
Are you interested in being invited to SSMP sponsored events at major shows?
Data Name Data Type Options
Physician Name:   Text Box
Email   Text Box
Home address   Text Box
City   Text Box
State   Text Box
Zipcode   Text Box
  checklist Are you interested in being invited to SSMP sponsored events at major shows?
  checklist Yes

Comments about 2-sight

No Comments
Comment by: admin
Comment on: 01/09/2020